EMEA-001944-PIP01-16-M05 - paediatric investigation plan

vadadustat
PIPHuman

Key facts

Invented name
Vafseo
Active Substance
vadadustat
Therapeutic area
Blood and lymphatic system disorders
Decision number
P/0290/2024
PIP number
EMEA-001944-PIP01-16-M05
Pharmaceutical form(s)
  • Tablet
  • Age appropriate oral formulation
Condition(s) / indication(s)
Treatment of anaemia due to chronic disorders
Route(s) of administration
Oral use
Contact for public enquiries

Akebia Europe Limited
E-mail: info@akebia.com
Tel. +1 6178712098
 

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page